Atlas Trials

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Clinical trial NCT00917293 · TERMINATED

Trial details

NCT number
NCT00917293
Sponsor
Medicure
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Tardive Dyskinesia
Start date
2009-05-01
Primary completion
2012-08-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.